prednisolone has been researched along with Osteoporotic Fractures in 9 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Osteoporotic Fractures: Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results revealed that COPD was significantly associated with a high risk of osteoporosis, regardless of whether the patients with COPD were corticosteroid users and irrespective of age and sex." | 1.42 | Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. ( Chang, KH; Chen, SJ; Huang, KH; Kao, CH; Kung, PT; Liao, WC; Lin, CL; Tsai, WC, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamborrini, G | 1 |
| Moser, F | 1 |
| Sterki Novakova, K | 1 |
| Chen, SJ | 1 |
| Liao, WC | 1 |
| Huang, KH | 1 |
| Lin, CL | 1 |
| Tsai, WC | 1 |
| Kung, PT | 1 |
| Chang, KH | 1 |
| Kao, CH | 1 |
| Paggiosi, MA | 1 |
| Peel, NF | 1 |
| Eastell, R | 1 |
| Wang, B | 1 |
| Guo, H | 1 |
| Yuan, L | 1 |
| Huang, D | 1 |
| Zhang, H | 1 |
| Hao, D | 1 |
| Krasselt, M | 1 |
| Baerwald, C | 1 |
| Ashida, A | 1 |
| Fujii, Y | 1 |
| Matsumura, H | 1 |
| Tamai, H | 1 |
| Hayashi, K | 1 |
| Yamamoto, M | 1 |
| Murakawa, Y | 1 |
| Yamauchi, M | 1 |
| Kaji, H | 1 |
| Yamaguchi, T | 1 |
| Sugimoto, T | 1 |
| Miyakoshi, N | 1 |
| Sasaki, H | 1 |
| Kasukawa, Y | 1 |
| Kamo, K | 1 |
| Shimada, Y | 1 |
| Eiken, PA | 1 |
| Hansen, M | 1 |
| Kristensen, B | 1 |
| Langdahl, BL | 1 |
| Abrahamsen, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Radiofrequency Ablation of the Medial Branch Nerve as a Novel Treatment for Posterior Element Pain From Vertebral Compression Fractures[NCT03651804] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-04-10 | Suspended (stopped due to Difficulty recruiting members) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Osteoporotic Fractures
| Article | Year |
|---|---|
[An update on glucocorticoid-induced osteoporosis].
Topics: Administration, Oral; Bone Density; Calcium, Dietary; Cholecalciferol; Dose-Response Relationship, D | 2016 |
1 trial available for prednisolone and Osteoporotic Fractures
| Article | Year |
|---|---|
A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Back Pain; Disability Evaluation; Female; Fractures, Co | 2016 |
7 other studies available for prednisolone and Osteoporotic Fractures
| Article | Year |
|---|---|
Topics: Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Ophthalmic Solutions; Osteoporosis, Postmen | 2018 |
Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study.
Topics: Adult; Age Distribution; Aged; Cohort Studies; Comorbidity; Databases, Factual; Female; Glucocortico | 2015 |
The impact of glucocorticoid therapy on trabecular bone score in older women.
Topics: Absorptiometry, Photon; Aged; Anthropometry; Bone Density; Cross-Sectional Studies; Female; Glucocor | 2015 |
A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.
Topics: Bone Density; Child; Drug Administration Schedule; Fractures, Compression; Glucocorticoids; Humans; | 2017 |
Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Drug Administ | 2009 |
Effects of a vitamin D analog, alfacalcidol, on bone and skeletal muscle in glucocorticoid-treated rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Glucocorticoids; Hy | 2010 |
[Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer].
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; G | 2011 |